- Home
- SYPR vs TENX Comparison
SYPR vs TENX Comparison
Compare SYPR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYPR | TENX |
|---|---|---|
| Founded | 1997 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 56.2M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYPR | TENX |
|---|---|---|
| Price | $2.42 | $12.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 70.2K | ★ 206.8K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $123,055,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.42 | $4.63 |
| 52 Week High | $3.72 | $14.22 |
Technical Indicators
Market Signals| Indicator | SYPR | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 64.76 |
| Support Level | $2.11 | $11.70 |
| Resistance Level | $2.72 | $13.00 |
| Average True Range (ATR) | 0.21 | 0.98 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 56.45 | 55.63 |
Price Performance
Historical ComparisonAbout SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.